Patient-reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study-Reference-Cited by-同舟云学术

Patient-reported symptoms and stepwise symptom management in patients on epidermal growth factor inhibitors: A retrospective, descriptive cohort study

Published:2018-01-04 Issue:2 Volume:27 Page:e12800
ISSN:0961-5423
Container-title:European Journal of Cancer Care
language:en
Short-container-title:Eur J Cancer Care

Author:

Koldenhof J.J.¹^ORCID,Langenberg M.H.G.¹,Witteveen P.O.¹,Teunissen S.C.C.M.²

Affiliation:

1. Department of Medical Oncology; Cancer Center; University Medical Center Utrecht; Utrecht the Netherlands

2. Department of Primary Care; Julius Center for Health Sciences and Primary Care; University Medical Center Utrecht; Utrecht the Netherlands

Publisher

Wiley

Subject

Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ecc.12800/fullpdf

Reference35 articles.

1. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors;Agero;Journal of the American Academy of Dermatology,2006

2. Approximate is better than “exact” for interval estimation of binomial proportions;Agresti;The American Statistician,1998

3. Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: An early and a late phase of papulopustular eruptions;Amitay-Laish;Oncologist,2010

4. EGFR-targeting monoclonal antibodies in head and neck cancer;Astsaturov;Current Cancer Drug Targets,2006

5. Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck;Bernier;Annals of Oncology,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective practice survey of management of cetuximab-related skin reactions;Supportive Care in Cancer;2020-11-04

2. Relationship between the Functional Oral Intake Scale (FOIS) and the Self-Efficacy Scale among Cancer Patients: A Cross-Sectional Study;Healthcare;2020-08-13

3. Validation of the Dutch version of the Edmonton Symptom Assessment System;Cancer Medicine;2020-07-09